Clinical Trial: Chemotherapy-Induced Peripheral Neuropathy - Additional Evaluation in Breast Cancer Survivors

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07604441) titled 'Chemotherapy-Induced Peripheral Neuropathy - Additional Evaluation in Breast Cancer Survivors' on May 17.

Brief Summary: The main goal of this trial is to identify the optimal cut-off score of a Scoring System to discriminate between mild chemotherapy-induced peripheral neuropathy (CIPN) and no CIPN in breast cancer survivors previously treated with taxane-based chemotherapy and adjuvant radiotherapy.

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: DIAGNOSTIC_TEST: Symptom-based scoring system

The patients will be asked to complete the self-evaluation of symptoms and signs of neuropa...